← Compare landing
Cisema vs Clarenta
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Cisema | Clarenta |
|---|---|---|
| Summary | Cisema supports medical device, IVD, pharmaceutical, and cosmetics companies with NMPA-related product registration, China device clinical studies, and local authorized representative services across China and Asia Pacific. Its offerings also include vigilance and post-market surveillance, quality compliance, and reimbursement market access work. | Clarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases. |
| Services |
|
|
| Modalities | Data not yet provided. | Data not yet provided. |
| Indications | Data not yet provided. |
|
| Phases | Data not yet provided. |
|
| Sourcing models | Data not yet provided. |
|
| Locations |
|
|
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/cisema/comac-medical.md